Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 5NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Melanoma 1Clear-cell metastatic renal cell carcinoma 1Carcinoma, Renal Cell 1Advanced Solid Tumors 1

Interventions

Sunitinib 4Ipilimumab 3pazopanib 2fludarabine 2Nivolumab 2cabozantinib 1atezolizumab 1Specimen Handling 1Magnetic Resonance Spectroscopy 1LY2510924 1Cyclophosphamide 1CTLA-4 Antigen 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Clear-cell metastatic renal cell carcinoma × CTLA-4 Antigen × Clear all
NCT06399419 2024-05-30

CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer

Osel, Inc.

Phase 1 Recruiting
28 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡